Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models.
This report aims to provide a comprehensive presentation of the global market for Computational Medicine and Drug Discovery Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Medicine and Drug Discovery Software. This report contains market size and forecasts of Computational Medicine and Drug Discovery Software in global, including the following market information:
Global Computational Medicine and Drug Discovery Software Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Computational Medicine and Drug Discovery Software market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The computational medicine and drug discovery market is poised to grow at a CAGR of 5.1% to reach $6.78 Billion by 2020.
We surveyed the Computational Medicine and Drug Discovery Software companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Computational Medicine and Drug Discovery Software Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Computational Medicine and Drug Discovery Software Market Segment Percentages, by Type, 2022 (%)
Database
Software
Others
Global Computational Medicine and Drug Discovery Software Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Computational Medicine and Drug Discovery Software Market Segment Percentages, by Application, 2022 (%)
Computational Physiological Medicine
Drug Discovery And Development
Medical Imaging
Disease Modeling
Predictive Analysis Of Drug Targets
Cellular Simulation
Simulation Software
Global Computational Medicine and Drug Discovery Software Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Computational Medicine and Drug Discovery Software Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Computational Medicine and Drug Discovery Software revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Computational Medicine and Drug Discovery Software revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Entelos
Genedata
Crown Bioscience
Biognos
Chemical Computing Group
Leadscope
Nimbus Therapeutics
Rhenovia Pharma Limited
Schrodinger
Compugen
Dassault Systemes
Outline of Major Chapters:
Chapter 1: Introduces the definition of Computational Medicine and Drug Discovery Software, market overview.
Chapter 2: Global Computational Medicine and Drug Discovery Software market size in revenue.
Chapter 3: Detailed analysis of Computational Medicine and Drug Discovery Software company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Computational Medicine and Drug Discovery Software in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Computational Medicine and Drug Discovery Software Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Computational Medicine and Drug Discovery Software Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Computational Medicine and Drug Discovery Software Overall Market Size
2.1 Global Computational Medicine and Drug Discovery Software Market Size: 2022 VS 2030
2.2 Global Computational Medicine and Drug Discovery Software Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Computational Medicine and Drug Discovery Software Players in Global Market
3.2 Top Global Computational Medicine and Drug Discovery Software Companies Ranked by Revenue
3.3 Global Computational Medicine and Drug Discovery Software Revenue by Companies
3.4 Top 3 and Top 5 Computational Medicine and Drug Discovery Software Companies in Global Market, by Revenue in 2022
3.5 Global Companies Computational Medicine and Drug Discovery Software Product Type
3.6 Tier 1, Tier 2 and Tier 3 Computational Medicine and Drug Discovery Software Players in Global Market
3.6.1 List of Global Tier 1 Computational Medicine and Drug Discovery Software Companies
3.6.2 List of Global Tier 2 and Tier 3 Computational Medicine and Drug Discovery Software Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Computational Medicine and Drug Discovery Software Market Size Markets, 2022 & 2030
4.1.2 Database
4.1.3 Software
4.1.4 Others
4.2 By Type - Global Computational Medicine and Drug Discovery Software Revenue & Forecasts
4.2.1 By Type - Global Computational Medicine and Drug Discovery Software Revenue, 2018-2023
4.2.2 By Type - Global Computational Medicine and Drug Discovery Software Revenue, 2024-2030
4.2.3 By Type - Global Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Computational Medicine and Drug Discovery Software Market Size, 2022 & 2030
5.1.2 Computational Physiological Medicine
5.1.3 Drug Discovery And Development
5.1.4 Medical Imaging
5.1.5 Disease Modeling
5.1.6 Predictive Analysis Of Drug Targets
5.1.7 Cellular Simulation
5.1.8 Simulation Software
5.2 By Application - Global Computational Medicine and Drug Discovery Software Revenue & Forecasts
5.2.1 By Application - Global Computational Medicine and Drug Discovery Software Revenue, 2018-2023
5.2.2 By Application - Global Computational Medicine and Drug Discovery Software Revenue, 2024-2030
5.2.3 By Application - Global Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Computational Medicine and Drug Discovery Software Market Size, 2022 & 2030
6.2 By Region - Global Computational Medicine and Drug Discovery Software Revenue & Forecasts
6.2.1 By Region - Global Computational Medicine and Drug Discovery Software Revenue, 2018-2023
6.2.2 By Region - Global Computational Medicine and Drug Discovery Software Revenue, 2024-2030
6.2.3 By Region - Global Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Computational Medicine and Drug Discovery Software Revenue, 2018-2030
6.3.2 US Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.3.3 Canada Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.3.4 Mexico Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Computational Medicine and Drug Discovery Software Revenue, 2018-2030
6.4.2 Germany Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.4.3 France Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.4.4 U.K. Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.4.5 Italy Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.4.6 Russia Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.4.7 Nordic Countries Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.4.8 Benelux Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Computational Medicine and Drug Discovery Software Revenue, 2018-2030
6.5.2 China Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.5.3 Japan Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.5.4 South Korea Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.5.5 Southeast Asia Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.5.6 India Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Computational Medicine and Drug Discovery Software Revenue, 2018-2030
6.6.2 Brazil Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.6.3 Argentina Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Computational Medicine and Drug Discovery Software Revenue, 2018-2030
6.7.2 Turkey Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.7.3 Israel Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.7.4 Saudi Arabia Computational Medicine and Drug Discovery Software Market Size, 2018-2030
6.7.5 UAE Computational Medicine and Drug Discovery Software Market Size, 2018-2030
7 Computational Medicine and Drug Discovery Software Companies Profiles
7.1 Entelos
7.1.1 Entelos Company Summary
7.1.2 Entelos Business Overview
7.1.3 Entelos Computational Medicine and Drug Discovery Software Major Product Offerings
7.1.4 Entelos Computational Medicine and Drug Discovery Software Revenue in Global Market (2018-2023)
7.1.5 Entelos Key News & Latest Developments
7.2 Genedata
7.2.1 Genedata Company Summary
7.2.2 Genedata Business Overview
7.2.3 Genedata Computational Medicine and Drug Discovery Software Major Product Offerings
7.2.4 Genedata Computational Medicine and Drug Discovery Software Revenue in Global Market (2018-2023)
7.2.5 Genedata Key News & Latest Developments
7.3 Crown Bioscience
7.3.1 Crown Bioscience Company Summary
7.3.2 Crown Bioscience Business Overview
7.3.3 Crown Bioscience Computational Medicine and Drug Discovery Software Major Product Offerings
7.3.4 Crown Bioscience Computational Medicine and Drug Discovery Software Revenue in Global Market (2018-2023)
7.3.5 Crown Bioscience Key News & Latest Developments
7.4 Biognos
7.4.1 Biognos Company Summary
7.4.2 Biognos Business Overview
7.4.3 Biognos Computational Medicine and Drug Discovery Software Major Product Offerings
7.4.4 Biognos Computational Medicine and Drug Discovery Software Revenue in Global Market (2018-2023)
7.4.5 Biognos Key News & Latest Developments
7.5 Chemical Computing Group
7.5.1 Chemical Computing Group Company Summary
7.5.2 Chemical Computing Group Business Overview
7.5.3 Chemical Computing Group Computational Medicine and Drug Discovery Software Major Product Offerings
7.5.4 Chemical Computing Group Computational Medicine and Drug Discovery Software Revenue in Global Market (2018-2023)
7.5.5 Chemical Computing Group Key News & Latest Developments
7.6 Leadscope
7.6.1 Leadscope Company Summary
7.6.2 Leadscope Business Overview
7.6.3 Leadscope Computational Medicine and Drug Discovery Software Major Product Offerings
7.6.4 Leadscope Computational Medicine and Drug Discovery Software Revenue in Global Market (2018-2023)
7.6.5 Leadscope Key News & Latest Developments
7.7 Nimbus Therapeutics
7.7.1 Nimbus Therapeutics Company Summary
7.7.2 Nimbus Therapeutics Business Overview
7.7.3 Nimbus Therapeutics Computational Medicine and Drug Discovery Software Major Product Offerings
7.7.4 Nimbus Therapeutics Computational Medicine and Drug Discovery Software Revenue in Global Market (2018-2023)
7.7.5 Nimbus Therapeutics Key News & Latest Developments
7.8 Rhenovia Pharma Limited
7.8.1 Rhenovia Pharma Limited Company Summary
7.8.2 Rhenovia Pharma Limited Business Overview
7.8.3 Rhenovia Pharma Limited Computational Medicine and Drug Discovery Software Major Product Offerings
7.8.4 Rhenovia Pharma Limited Computational Medicine and Drug Discovery Software Revenue in Global Market (2018-2023)
7.8.5 Rhenovia Pharma Limited Key News & Latest Developments
7.9 Schrodinger
7.9.1 Schrodinger Company Summary
7.9.2 Schrodinger Business Overview
7.9.3 Schrodinger Computational Medicine and Drug Discovery Software Major Product Offerings
7.9.4 Schrodinger Computational Medicine and Drug Discovery Software Revenue in Global Market (2018-2023)
7.9.5 Schrodinger Key News & Latest Developments
7.10 Compugen
7.10.1 Compugen Company Summary
7.10.2 Compugen Business Overview
7.10.3 Compugen Computational Medicine and Drug Discovery Software Major Product Offerings
7.10.4 Compugen Computational Medicine and Drug Discovery Software Revenue in Global Market (2018-2023)
7.10.5 Compugen Key News & Latest Developments
7.11 Dassault Systemes
7.11.1 Dassault Systemes Company Summary
7.11.2 Dassault Systemes Business Overview
7.11.3 Dassault Systemes Computational Medicine and Drug Discovery Software Major Product Offerings
7.11.4 Dassault Systemes Computational Medicine and Drug Discovery Software Revenue in Global Market (2018-2023)
7.11.5 Dassault Systemes Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Computational Medicine and Drug Discovery Software Market Opportunities & Trends in Global Market
Table 2. Computational Medicine and Drug Discovery Software Market Drivers in Global Market
Table 3. Computational Medicine and Drug Discovery Software Market Restraints in Global Market
Table 4. Key Players of Computational Medicine and Drug Discovery Software in Global Market
Table 5. Top Computational Medicine and Drug Discovery Software Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Computational Medicine and Drug Discovery Software Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Computational Medicine and Drug Discovery Software Revenue Share by Companies, 2018-2023
Table 8. Global Companies Computational Medicine and Drug Discovery Software Product Type
Table 9. List of Global Tier 1 Computational Medicine and Drug Discovery Software Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Computational Medicine and Drug Discovery Software Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Computational Medicine and Drug Discovery Software Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Computational Medicine and Drug Discovery Software Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Computational Medicine and Drug Discovery Software Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Computational Medicine and Drug Discovery Software Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Computational Medicine and Drug Discovery Software Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Computational Medicine and Drug Discovery Software Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2024-2030
Table 30. Entelos Company Summary
Table 31. Entelos Computational Medicine and Drug Discovery Software Product Offerings
Table 32. Entelos Computational Medicine and Drug Discovery Software Revenue (US$, Mn) & (2018-2023)
Table 33. Entelos Key News & Latest Developments
Table 34. Genedata Company Summary
Table 35. Genedata Computational Medicine and Drug Discovery Software Product Offerings
Table 36. Genedata Computational Medicine and Drug Discovery Software Revenue (US$, Mn) & (2018-2023)
Table 37. Genedata Key News & Latest Developments
Table 38. Crown Bioscience Company Summary
Table 39. Crown Bioscience Computational Medicine and Drug Discovery Software Product Offerings
Table 40. Crown Bioscience Computational Medicine and Drug Discovery Software Revenue (US$, Mn) & (2018-2023)
Table 41. Crown Bioscience Key News & Latest Developments
Table 42. Biognos Company Summary
Table 43. Biognos Computational Medicine and Drug Discovery Software Product Offerings
Table 44. Biognos Computational Medicine and Drug Discovery Software Revenue (US$, Mn) & (2018-2023)
Table 45. Biognos Key News & Latest Developments
Table 46. Chemical Computing Group Company Summary
Table 47. Chemical Computing Group Computational Medicine and Drug Discovery Software Product Offerings
Table 48. Chemical Computing Group Computational Medicine and Drug Discovery Software Revenue (US$, Mn) & (2018-2023)
Table 49. Chemical Computing Group Key News & Latest Developments
Table 50. Leadscope Company Summary
Table 51. Leadscope Computational Medicine and Drug Discovery Software Product Offerings
Table 52. Leadscope Computational Medicine and Drug Discovery Software Revenue (US$, Mn) & (2018-2023)
Table 53. Leadscope Key News & Latest Developments
Table 54. Nimbus Therapeutics Company Summary
Table 55. Nimbus Therapeutics Computational Medicine and Drug Discovery Software Product Offerings
Table 56. Nimbus Therapeutics Computational Medicine and Drug Discovery Software Revenue (US$, Mn) & (2018-2023)
Table 57. Nimbus Therapeutics Key News & Latest Developments
Table 58. Rhenovia Pharma Limited Company Summary
Table 59. Rhenovia Pharma Limited Computational Medicine and Drug Discovery Software Product Offerings
Table 60. Rhenovia Pharma Limited Computational Medicine and Drug Discovery Software Revenue (US$, Mn) & (2018-2023)
Table 61. Rhenovia Pharma Limited Key News & Latest Developments
Table 62. Schrodinger Company Summary
Table 63. Schrodinger Computational Medicine and Drug Discovery Software Product Offerings
Table 64. Schrodinger Computational Medicine and Drug Discovery Software Revenue (US$, Mn) & (2018-2023)
Table 65. Schrodinger Key News & Latest Developments
Table 66. Compugen Company Summary
Table 67. Compugen Computational Medicine and Drug Discovery Software Product Offerings
Table 68. Compugen Computational Medicine and Drug Discovery Software Revenue (US$, Mn) & (2018-2023)
Table 69. Compugen Key News & Latest Developments
Table 70. Dassault Systemes Company Summary
Table 71. Dassault Systemes Computational Medicine and Drug Discovery Software Product Offerings
Table 72. Dassault Systemes Computational Medicine and Drug Discovery Software Revenue (US$, Mn) & (2018-2023)
Table 73. Dassault Systemes Key News & Latest Developments
List of Figures
Figure 1. Computational Medicine and Drug Discovery Software Segment by Type in 2022
Figure 2. Computational Medicine and Drug Discovery Software Segment by Application in 2022
Figure 3. Global Computational Medicine and Drug Discovery Software Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Computational Medicine and Drug Discovery Software Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Computational Medicine and Drug Discovery Software Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Computational Medicine and Drug Discovery Software Revenue in 2022
Figure 8. By Type - Global Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
Figure 9. By Application - Global Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
Figure 10. By Type - Global Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
Figure 12. By Application - Global Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
Figure 14. By Region - Global Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
Figure 15. By Country - North America Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
Figure 16. US Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
Figure 20. Germany Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 21. France Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
Figure 28. China Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 32. India Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
Figure 34. Brazil Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Computational Medicine and Drug Discovery Software Revenue Market Share, 2018-2030
Figure 37. Turkey Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Computational Medicine and Drug Discovery Software Revenue, (US$, Mn), 2018-2030
Figure 41. Entelos Computational Medicine and Drug Discovery Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Genedata Computational Medicine and Drug Discovery Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Crown Bioscience Computational Medicine and Drug Discovery Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biognos Computational Medicine and Drug Discovery Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Chemical Computing Group Computational Medicine and Drug Discovery Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Leadscope Computational Medicine and Drug Discovery Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Nimbus Therapeutics Computational Medicine and Drug Discovery Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Rhenovia Pharma Limited Computational Medicine and Drug Discovery Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Schrodinger Computational Medicine and Drug Discovery Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Compugen Computational Medicine and Drug Discovery Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Dassault Systemes Computational Medicine and Drug Discovery Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
